Risk and Benefit for Targeted Therapy Agents in Pediatric Phase II Trials in Oncology: A Systematic Review with a Meta-Analysis

BACKGROUND: For research with human participants to be ethical, risk must be in a favorable balance with potential benefits. Little is known about the risk/benefit ratio for pediatric cancer phase II trials testing targeted therapies. OBJECTIVE: Our aim was to conduct a systematic review of prelimin...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Target Oncol
मुख्य लेखकों: Strzebonska, Karolina, Wasylewski, Mateusz T., Zaborowska, Lucja, Polak, Maciej, Slugocka, Emilia, Stras, Jakub, Blukacz, Mateusz, Gyawali, Bishal, Waligora, Marcin
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Springer International Publishing 2021
विषय:
Systematic Review
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC8266705/
https://ncbi.nlm.nih.gov/pubmed/34110559
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11523-021-00822-5
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन